These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24780541)

  • 1. Low fasting plasma glucose level predicts morbidity and mortality in symptomatic adults with congenital heart disease.
    Ohuchi H; Yasuda K; Ono S; Hayama Y; Negishi J; Noritake K; Mizuno M; Iwasa T; Miyazaki A; Yamada O
    Int J Cardiol; 2014 Jun; 174(2):306-12. PubMed ID: 24780541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease.
    Ohuchi H; Miyamoto Y; Yamamoto M; Ishihara H; Takata H; Miyazaki A; Yamada O; Yagihara T
    Am Heart J; 2009 Jul; 158(1):30-9. PubMed ID: 19540389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geriatric congenital heart disease: burden of disease and predictors of mortality.
    Afilalo J; Therrien J; Pilote L; Ionescu-Ittu R; Martucci G; Marelli AJ
    J Am Coll Cardiol; 2011 Sep; 58(14):1509-15. PubMed ID: 21939837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic importance of abnormal glucose metabolism in chronic heart failure].
    Guo JC; Li ZP; Gao W; Guo YH; Mao JM
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1385-8. PubMed ID: 20646626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
    J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study).
    Simons LA; Simons J; Friedlander Y; McCallum J
    Am J Cardiol; 2008 Oct; 102(7):831-4. PubMed ID: 18805106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of von Willebrand factor in adult patients with congenital heart disease.
    Ohuchi H; Hayama Y; Miike H; Suzuki D; Nakajima K; Iwasa T; Konagai N; Sakaguchi H; Miyazaki A; Shiraishi I; Kurosaki KI; Nakai M
    Heart; 2020 Jun; 106(12):910-915. PubMed ID: 32188625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States.
    Rodriguez FH; Moodie DS; Parekh DR; Franklin WJ; Morales DL; Zafar F; Adams GJ; Friedman RA; Rossano JW
    Congenit Heart Dis; 2013; 8(6):513-9. PubMed ID: 23164196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality.
    Tutarel O; Kempny A; Alonso-Gonzalez R; Jabbour R; Li W; Uebing A; Dimopoulos K; Swan L; Gatzoulis MA; Diller GP
    Eur Heart J; 2014 Mar; 35(11):725-32. PubMed ID: 23882067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate response during exercise predicts survival in adults with congenital heart disease.
    Diller GP; Dimopoulos K; Okonko D; Uebing A; Broberg CS; Babu-Narayan S; Bayne S; Poole-Wilson PA; Sutton R; Francis DP; Gatzoulis MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1250-6. PubMed ID: 16979014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia in adults with congenital heart disease relates to adverse outcome.
    Dimopoulos K; Diller GP; Giannakoulas G; Petraco R; Chamaidi A; Karaoli E; Mullen M; Swan L; Piepoli MF; Poole-Wilson PA; Francis DP; Gatzoulis MA
    J Am Coll Cardiol; 2009 Nov; 54(22):2093-100. PubMed ID: 19926019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome].
    Vivas D; García-Rubira JC; González-Ferrer JJ; Núñez-Gil I; del Prado N; Fernández-Ortiz A; Macaya C
    Rev Esp Cardiol; 2008 May; 61(5):458-64. PubMed ID: 18462648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal glucose metabolism in patients with Fontan circulation: Unique characteristics and associations with Fontan pathophysiology.
    Ohuchi H; Negishi J; Hayama Y; Miike H; Suzuki D; Nakajima K; Konagai N; Iwasa T; Sakaguchi H; Kurosaki K; Nakai M
    Am Heart J; 2019 Oct; 216():125-135. PubMed ID: 31425899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-hour post-challenge glucose is a better predictor of adverse outcome after myocardial infarction than fasting or admission glucose in patients without diabetes.
    Chattopadhyay S; George A; John J; Sathyapalan T
    Acta Diabetol; 2018 May; 55(5):449-458. PubMed ID: 29450734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men.
    Park YW; Chang Y; Sung KC; Ryu S; Sung E; Kim WS
    Diabetes Res Clin Pract; 2006 Sep; 73(3):329-35. PubMed ID: 16600415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized adult congenital heart disease care: the impact of policy on mortality.
    Mylotte D; Pilote L; Ionescu-Ittu R; Abrahamowicz M; Khairy P; Therrien J; Mackie AS; Marelli A
    Circulation; 2014 May; 129(18):1804-12. PubMed ID: 24589851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.
    Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
    J Diabetes Complications; 2013; 27(6):593-6. PubMed ID: 23890682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the Seattle Heart Failure Model to identify adults with congenital heart disease at high risk of poor outcome.
    Stefanescu A; Macklin EA; Lin E; Dudzinski DM; Johnson J; Kennedy KF; Jacoby D; DeFaria Yeh D; Lewis GD; Yeh RW; Liberthson R; Lui G; Bhatt AB
    Am J Cardiol; 2014 Mar; 113(5):865-70. PubMed ID: 24411285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease.
    Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY;
    Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.
    Diller GP; Dimopoulos K; Okonko D; Li W; Babu-Narayan SV; Broberg CS; Johansson B; Bouzas B; Mullen MJ; Poole-Wilson PA; Francis DP; Gatzoulis MA
    Circulation; 2005 Aug; 112(6):828-35. PubMed ID: 16061735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.